Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
NCT01638572
·
clinicaltrials.gov ↗
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Sponsor
National Taiwan University Hospital